BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 32462247)

  • 1. [CD28 costimulation and checkpoint inhibition in T cells].
    Beyersdorf N; Kerkau T
    Internist (Berl); 2020 Jul; 61(7):652-659. PubMed ID: 32462247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Costimulation of T lymphocytes with integrin ligands intercellular adhesion molecule-1 or vascular cell adhesion molecule-1 induces functional expression of CTLA-4, a second receptor for B7.
    Damle NK; Klussman K; Leytze G; Myrdal S; Aruffo A; Ledbetter JA; Linsley PS
    J Immunol; 1994 Mar; 152(6):2686-97. PubMed ID: 7511623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T cell checkpoint regulators in the heart.
    Grabie N; Lichtman AH; Padera R
    Cardiovasc Res; 2019 Apr; 115(5):869-877. PubMed ID: 30721928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD28 function: a balance of costimulatory and regulatory signals.
    Bour-Jordan H; Blueston JA
    J Clin Immunol; 2002 Jan; 22(1):1-7. PubMed ID: 11958588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and functional significance of CTLA-4, a negative regulator of T cell activation.
    Kosmaczewska A; Ciszak L; Boćko D; Frydecka I
    Arch Immunol Ther Exp (Warsz); 2001; 49(1):39-46. PubMed ID: 11266089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of the role of negative T cell costimulatory pathways in CD4 and CD8 T cell-mediated alloimmune responses in vivo.
    Ito T; Ueno T; Clarkson MR; Yuan X; Jurewicz MM; Yagita H; Azuma M; Sharpe AH; Auchincloss H; Sayegh MH; Najafian N
    J Immunol; 2005 Jun; 174(11):6648-56. PubMed ID: 15905503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T cell costimulation, checkpoint inhibitors and anti-tumor therapy.
    Nandi D; Pathak S; Verma T; Singh M; Chattopadhyay A; Thakur S; Raghavan A; Gokhroo A; Vijayamahantesh
    J Biosci; 2020; 45():. PubMed ID: 32345776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD28 Costimulation: From Mechanism to Therapy.
    Esensten JH; Helou YA; Chopra G; Weiss A; Bluestone JA
    Immunity; 2016 May; 44(5):973-88. PubMed ID: 27192564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Signaling through CD28 and CTLA-4 controls two distinct forms of T cell anergy.
    Wells AD; Walsh MC; Bluestone JA; Turka LA
    J Clin Invest; 2001 Sep; 108(6):895-903. PubMed ID: 11560959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting T cell costimulation in autoimmune disease.
    Stuart RW; Racke MK
    Expert Opin Ther Targets; 2002 Jun; 6(3):275-89. PubMed ID: 12223069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A transendocytosis perspective on the CD28/CTLA-4 pathway.
    Soskic B; Qureshi OS; Hou T; Sansom DM
    Adv Immunol; 2014; 124():95-136. PubMed ID: 25175774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Control of peripheral T-cell tolerance and autoimmunity via the CTLA-4 and PD-1 pathways.
    Fife BT; Bluestone JA
    Immunol Rev; 2008 Aug; 224():166-82. PubMed ID: 18759926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Negative co-receptors on lymphocytes.
    Greenwald RJ; Latchman YE; Sharpe AH
    Curr Opin Immunol; 2002 Jun; 14(3):391-6. PubMed ID: 11973140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CTLA-4, an Essential Immune-Checkpoint for T-Cell Activation.
    Chikuma S
    Curr Top Microbiol Immunol; 2017; 410():99-126. PubMed ID: 28900679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Costimulation requirements of induced murine systemic autoimmune disease.
    Pollard KM; Arnush M; Hultman P; Kono DH
    J Immunol; 2004 Nov; 173(9):5880-7. PubMed ID: 15494542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytotoxic T lymphocyte antigen 4 and CD28 modulate cell surface raft expression in their regulation of T cell function.
    Martin M; Schneider H; Azouz A; Rudd CE
    J Exp Med; 2001 Dec; 194(11):1675-81. PubMed ID: 11733581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coexpression and functional cooperation of CTLA-4 and CD28 on activated T lymphocytes.
    Linsley PS; Greene JL; Tan P; Bradshaw J; Ledbetter JA; Anasetti C; Damle NK
    J Exp Med; 1992 Dec; 176(6):1595-604. PubMed ID: 1334116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD28-independent costimulation of T cells in alloimmune responses.
    Yamada A; Kishimoto K; Dong VM; Sho M; Salama AD; Anosova NG; Benichou G; Mandelbrot DA; Sharpe AH; Turka LA; Auchincloss H; Sayegh MH
    J Immunol; 2001 Jul; 167(1):140-6. PubMed ID: 11418642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of TCR-induced transcriptional profiles by ligation of CD28, ICOS, and CTLA-4 receptors.
    Riley JL; Mao M; Kobayashi S; Biery M; Burchard J; Cavet G; Gregson BP; June CH; Linsley PS
    Proc Natl Acad Sci U S A; 2002 Sep; 99(18):11790-5. PubMed ID: 12195015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The CD28-B7 costimulatory pathway and its role in autoimmune disease.
    Daikh D; Wofsy D; Imboden JB
    J Leukoc Biol; 1997 Aug; 62(2):156-62. PubMed ID: 9261329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.